NYSE
222.00USD
+0.03 (+0.01%)
We have scored 35 news catalysts on ResMed Inc. (RMD) over the past 12 months. The biggest single-day move next to one of them came May 11, 2026, when RMD closed −3.9%: “Jim Cramer says today's market is punishing stocks harder than 1999”. Coverage across the window leans positive (average ticker sentiment +0.31). Most of the impact sits in sector healthcare and geographic supply risk.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
32.2B
P/E
—
EPS
—
Beta
0.77
52W range
180.27-284.87
Day range
221.75–225.09
Open
222.78
Prev close
221.97
Volume
536.5K
Avg volume
1.5M
Dividend
2.46
IPO
1995-06-02
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about ResMed Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for RMD: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
